Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (51-60 of 204) with videos related to

Pageof 21
Sort By:
Journal of Neuroinflammation|June 7, 2017
Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune systemNádia Pereira Gonçalves, João Moreira, Diana Martins, et al.
Clinical Nuclear Medicine|March 6, 2015
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathySimone Longhi, Rachele Bonfiglioli, Laura Obici, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II studyLaura Obici, Andrea Cortese, Alessandro Lozza, et al.
The Journal of Biological Chemistry|November 8, 2002
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-IAlessia Andreola, Vittorio Bellotti, Sofia Giorgetti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2023
Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III TrialMarco Gattorno, Laura Obici, Inmaculada Calvo Penadés, et al.
Blood|November 10, 2011
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44Vittorio Perfetti, Giovanni Palladini, Simona Casarini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 13, 2012
High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathyCandida Cristina Quarta, Laura Obici, Pier Luigi Guidalotti, et al.
American Journal of Hematology|March 6, 2012
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failureGiovanni Palladini, Andrea Foli, Paolo Milani, et al.
Annals of Hematology|May 3, 2011
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomideGiovanni Palladini, Paola Russo, Andrea Foli, et al.
Blood|April 9, 2004
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantationGiovanni Palladini, Vittorio Perfetti, Laura Obici, et al.
Pageof 21

Showing results (51-60 of 204) with videos related to

Sort By:
Pageof 21
Journal of Neuroinflammation|June 7, 2017
Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune systemNádia Pereira Gonçalves, João Moreira, Diana Martins, et al.
Clinical Nuclear Medicine|March 6, 2015
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathySimone Longhi, Rachele Bonfiglioli, Laura Obici, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II studyLaura Obici, Andrea Cortese, Alessandro Lozza, et al.
The Journal of Biological Chemistry|November 8, 2002
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-IAlessia Andreola, Vittorio Bellotti, Sofia Giorgetti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2023
Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III TrialMarco Gattorno, Laura Obici, Inmaculada Calvo Penadés, et al.
Blood|November 10, 2011
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44Vittorio Perfetti, Giovanni Palladini, Simona Casarini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 13, 2012
High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathyCandida Cristina Quarta, Laura Obici, Pier Luigi Guidalotti, et al.
American Journal of Hematology|March 6, 2012
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failureGiovanni Palladini, Andrea Foli, Paolo Milani, et al.
Annals of Hematology|May 3, 2011
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomideGiovanni Palladini, Paola Russo, Andrea Foli, et al.
Blood|April 9, 2004
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantationGiovanni Palladini, Vittorio Perfetti, Laura Obici, et al.
Pageof 21